Cargando…

Ex vivo assessment of chemotherapy sensitivity of colorectal cancer peritoneal metastases

Detalles Bibliográficos
Autores principales:	Cashin, Peter H, Söderström, Maria, Blom, Kristin, Artursson, Sara, Andersson, Claes, Larsson, Rolf, Nygren, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416678/ https://www.ncbi.nlm.nih.gov/pubmed/36918737 http://dx.doi.org/10.1093/bjs/znad066

Ejemplares similares

Activity ex vivo of cytotoxic drugs in patient samples of peritoneal carcinomatosis with special focus on colorectal cancer
por: Cashin, Peter H, et al.
Publicado: (2013)

Ex vivo assessment of cancer drug sensitivity in epithelial ovarian cancer and its association with histopathological type, treatment history and clinical outcome
por: Bjersand, Kathrine, et al.
Publicado: (2022)

Assessment in vitro of interactions between anti-cancer drugs and noncancer drugs commonly used by cancer patients
por: Andersson, Claes R., et al.
Publicado: (2022)

Sorafenib and nitazoxanide disrupt mitochondrial function and inhibit regrowth capacity in three-dimensional models of hepatocellular and colorectal carcinoma
por: Ek, Frida, et al.
Publicado: (2022)

Perioperative chemotherapy in colorectal cancer with peritoneal metastases: A global propensity score matched study
por: Cashin, Peter H., et al.
Publicado: (2022)

Benchmarking of gastric cancer sensitivity to anti-cancer drugs ex vivo as a basis for drug selection in systemic and intraperitoneal therapy
por: Hultman, Bo, et al.
Publicado: (2014)

Prognostic Impact of BRAF and KRAS Mutation in Patients with Colorectal and Appendiceal Peritoneal Metastases Scheduled for CRS and HIPEC
por: Graf, Wilhelm, et al.
Publicado: (2019)

Mebendazole stimulates CD14+ myeloid cells to enhance T-cell activation and tumour cell killing
por: Rubin, Jenny, et al.
Publicado: (2018)

Mebendazole-induced M1 polarisation of THP-1 macrophages may involve DYRK1B inhibition
por: Blom, Kristin, et al.
Publicado: (2019)

Treatment Response After Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Metastases of Colorectal Originf
por: Hübner, Martin, et al.
Publicado: (2022)

Improved survival in patients with peritoneal metastases from colorectal cancer: a preliminary study
por: Mahteme, H, et al.
Publicado: (2004)

Comparison of hyperthermic intraperitoneal chemotherapy regimens for treatment of peritoneal-metastasized colorectal cancer
por: Spiegelberg, Julia, et al.
Publicado: (2020)

Mebendazole is unique among tubulin-active drugs in activating the MEK–ERK pathway
por: Andersson, Claes R., et al.
Publicado: (2020)

Exploiting loss of heterozygosity for allele-selective colorectal cancer chemotherapy
por: Rendo, Veronica, et al.
Publicado: (2020)

Bliss and Loewe interaction analyses of clinically relevant drug combinations in human colon cancer cell lines reveal complex patterns of synergy and antagonism
por: Kashif, Muhammad, et al.
Publicado: (2017)

Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy
por: James, Mark I., et al.
Publicado: (2015)

Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy
por: Ubink, I., et al.
Publicado: (2019)

The importance of synchronicity in the management of colorectal peritoneal metastases with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Wong, Jolene Si Min, et al.
Publicado: (2020)

Drug Sensitivity Testing in Cytoreductive Surgery and Intraperitoneal Chemotherapy of Pseudomyxoma Peritonei
por: Bjersand, Kathrine, et al.
Publicado: (2015)

Prognostic Factors of Peritoneal Metastases from Colorectal Cancer following Cytoreductive Surgery and Perioperative Chemotherapy
por: Yonemura, Yutaka, et al.
Publicado: (2013)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: Where do we stand?
por: Witmer, Hunter D. D., et al.
Publicado: (2022)

Treatment of peritoneal metastases from colorectal cancer
por: März, Loreen, et al.
Publicado: (2015)

Colorectal peritoneal metastases: Optimal management review
por: Sánchez-Hidalgo, Juan Manuel, et al.
Publicado: (2019)

Cytoreductive Surgery of Colorectal Peritoneal Metastases: Outcomes after Complete Cytoreductive Surgery and Systemic Chemotherapy Only
por: Désolneux, Grégoire, et al.
Publicado: (2015)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Summary of Key Clinical Trials
por: Turner, Kevin M., et al.
Publicado: (2022)

The Impact of Neoadjuvant Chemotherapy on the Surgical Management of Colorectal Peritoneal Metastases: A Systematic Review and Meta-Analysis
por: Flood, Michael P., et al.
Publicado: (2022)

The Role of Prophylactic and Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Prevention of Peritoneal Metastases in Advanced Colorectal Cancer
por: Sun, Beatrice J., et al.
Publicado: (2023)

Cytoreductive surgery in combination with hyperthermic intraperitoneal chemotherapy improves survival in patients with colorectal peritoneal metastases compared with systemic chemotherapy alone
por: Mirnezami, R, et al.
Publicado: (2014)

Management of peritoneal surface metastases from colorectal cancer: Cytoreductive surgery, hyperthermic intraperitoneal chemotherapy, pressurized intraperitoneal chemotherapy, and beyond
por: Mangieri, Christopher W., et al.
Publicado: (2022)

Phenotypic screening platform identifies statins as enhancers of immune cell-induced cancer cell death
por: Selvin, Tove, et al.
Publicado: (2023)

Multidisciplinary Treatment for Colorectal Peritoneal Metastases: Review of the Literature
por: Mo, Shaobo, et al.
Publicado: (2016)

Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases From a Small Bowel Adenocarcinoma: Multi-Institutional Experience
por: Liu, Yang, et al.
Publicado: (2018)

Histological regression of gastrointestinal peritoneal metastases after systemic chemotherapy
por: Toussaint, Laura, et al.
Publicado: (2021)

ASCO 2016 – update colorectal liver metastases
por: Kaczirek, Klaus
Publicado: (2017)

Impact of Neoadjuvant Chemotherapy on the Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Multi-Institutional Retrospective Review
por: Beal, Eliza W., et al.
Publicado: (2020)

Hyperthermic intraperitoneal chemotherapy with cisplatin and mitomycin C for colorectal cancer peritoneal metastases: A systematic review of the literature
por: Pinto, Amandine, et al.
Publicado: (2019)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal peritoneal metastases: analysis of short- and long-term outcomes
por: Rosa, Fausto, et al.
Publicado: (2021)

ASO Author Reflections: Neoadjuvant Systemic Chemotherapy in Isolated Resectable Colorectal Peritoneal Metastases: Ready for Standard of Care?
por: Flood, Michael P., et al.
Publicado: (2022)

Hepatectomy for metachronous colorectal liver metastases following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases: a report of three cases
por: Ito, Kyoji, et al.
Publicado: (2019)

Ex Vivo Activity of Cardiac Glycosides in Acute Leukaemia
por: Hallböök, Helene, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_o4e5utnu341dhgfmfte7tif7sa